Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.
about
Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation.Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineDNA and RNA-based vaccines: principles, progress and prospects.Preclinical evaluation of the synthetic adjuvant SQS-21 and its constituent isomeric saponins.Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responsesImproved tuberculosis DNA vaccines by formulation in cationic lipids.Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulationsCationic microparticles: A potent delivery system for DNA vaccinesAdjuvant Effect of Quillaja saponaria Saponin (QSS) on Protective Efficacy and IgM Generation in Turbot (Scophthalmus maximus) upon Immersion Vaccination.Adjuvant effects of saponins on animal immune responsesCholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice.Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccinesA consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release.Recent Developments in Preclinical DNA Vaccination.Recent advances in the development of immunotherapies for tauopathiesSynthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.
P2860
Q30409922-05533965-AA0F-4111-AFE5-5C6622B61359Q33614476-A4DD1244-69F2-4825-BA2B-C094DB0C77ACQ33783789-201BAA52-7F6F-4D68-8DDE-D71547A20CE2Q33899683-F5F88DB1-0506-4EE2-A5E3-0FF3A9C1BF96Q34003547-E5838677-4500-40E0-8BCE-C2A2C2EBD4ADQ34078689-7F233B78-3E84-4E71-AAAA-FCD8EA9277C6Q34126930-135753C0-8247-4043-AB24-C31FD308E6E0Q34641666-E6502649-3FF6-464E-82D7-1CC90F1A14A4Q34978592-265B2232-2F50-4D18-B08D-310611E666C5Q36743593-659DBB03-754C-4E85-BFFE-A65CE38EFB93Q36745550-4BD1DDF6-134B-4BDA-9B6B-18E219ED8A12Q36977797-164B65CE-8AC8-493A-8A2A-0C0AD6ADFD2CQ37014879-A07E6A5B-20B4-419A-B160-7B177A6D5CE4Q37156758-C5AE8D5A-793D-4D62-B3AC-6B342A761AECQ37492797-916D4F4C-A2D0-4253-9BCE-F1A13D9DA7A8Q37638619-A1F5EBF7-9DC9-4D57-8684-3E50FF597448Q38581976-651D8696-FE8C-4094-AA36-E6FB15DA8F04Q42778736-B811E6BA-3E12-47FA-8962-471AF4E6CC53Q43218014-EB70C0FB-5F28-4522-A4F5-287F51087A74Q43482777-F3F05463-8031-4BE2-9A59-9A0C0018003DQ52725104-E1FBB3CD-4A8D-4387-91BB-C6D6DC3E72A3Q54230568-280105B3-5C19-4B47-9842-7D5986EE5059
P2860
Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Induction of systemic and muco ...... uscular and intranasal routes.
@ast
Induction of systemic and muco ...... uscular and intranasal routes.
@en
type
label
Induction of systemic and muco ...... uscular and intranasal routes.
@ast
Induction of systemic and muco ...... uscular and intranasal routes.
@en
prefLabel
Induction of systemic and muco ...... uscular and intranasal routes.
@ast
Induction of systemic and muco ...... uscular and intranasal routes.
@en
P2093
P2860
P1433
P1476
Induction of systemic and muco ...... uscular and intranasal routes.
@en
P2093
C R Kensil
J Fukushima
K Hamajima
S Kawamoto
P2860
P304
P577
1998-06-01T00:00:00Z